Discontinuation report ERYBID
| Report ID | 13638 |
| Drug Identification Number | 00893862 |
| Brand name | ERYBID |
| Common or Proper name | Erythromycin Tablets |
| Company Name | AMDIPHARM LIMITED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ERYTHROMYCIN |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | All |
| ATC code | J01FA |
| ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2017-06-21 |
| Remaining supply date | 2017-06-21 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3 BURLINGTON ROAD DUBLIN, LEINSTER IRELAND DUBLIN 4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-06-22 | French | Compare |
| v1 | 2017-06-22 | English | Compare |
Showing 1 to 2 of 2